tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market

Neuphoria Therapeutics (NEUP) Income Statement

Compare
242 Followers

Neuphoria Therapeutics Income Statement

Last quarter (Q3 2024), Neuphoria Therapeutics's total revenue was AU$15.00M, an increase of 8582.72% from the same quarter last year. In Q3, Neuphoria Therapeutics's net income was AU$11.26M. See Neuphoria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 22Jun 21Jun 20
Total Revenue
AU$ 0.00AU$ 181.36KAU$ 0.00AU$ 32.06K
Gross Profit
AU$ 0.00AU$ -9.94MAU$ 0.00AU$ -2.84M
Operating Expenses
AU$ 17.89MAU$ 14.86MAU$ 8.96MAU$ 6.23M
Depreciation and Amortization
AU$ 662.99KAU$ 763.17KAU$ 1.28MAU$ 1.68M
EBITDA
AU$ -17.13MAU$ -14.32MAU$ -4.51MAU$ -1.23M
Operating Income
AU$ -17.89MAU$ -14.68MAU$ -8.96MAU$ -6.19M
Other Income/Expenses
AU$ 2.31MAU$ -419.37KAU$ 2.28MAU$ 2.05M
Pretax Income
AU$ -15.58MAU$ -15.10MAU$ -6.68MAU$ -4.14M
Net Income
AU$ -15.49MAU$ -14.97MAU$ -6.53MAU$ -4.89M
Per Share Metrics
Basic EPS
AU$ -0.10AU$ -0.13AU$ -0.10AU$ -0.11
Diluted EPS
AU$ -0.10AU$ -0.13AU$ -0.10AU$ -0.11
Weighted Average Shares Outstanding
149.80M 112.78M 65.00M 45.41M
Weighted Average Shares Outstanding (Diluted)
149.80M 112.78M 65.00M 45.41M
Currency in AUD

Neuphoria Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis